Cytokinetics Announces Licensing Collaboration and Royalty Monetization Deals with RTW Investments Focused to CK-3773274, Next-Generation Cardiac Myosin Inhibitor
Go back to Cytokinetics Announces Licensing Collaboration and Royalty Monetization Deals with RTW Investments Focused to CK-3773274, Next-Generation Cardiac Myosin Inhibitor| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 68.78 -1.14 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.92 | 52 Week High | $13.18 | |||
| Open | $70.18 | 52 Week Low | $6.00 | |||
| Day High | $70.18 | P/E | N/A | |||
| Day Low | $68.15 | EPS | $-1.24 | |||
| Volume | 4,872,971 | |||||
